Search results for: 'biologics particip analyst'

Indonesia has gathered much attention after implementation of the National Healthcare Scheme or JKN. Due to the heavy demand of healthcare services and supplies, the market is expected to be an attraction for the next 2-3 years. The report evaluates the current scenario and shares the actual market conditions, hurdles and drivers for existing and n...

06 May 2016  |  Asia Pacific  |  Market Research

Global Generic Pharmaceuticals Market, Forecast to 2020

Market Participants Target High Value-added Branded Generics and Biosimilars Segments

Infographics

×

The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....

This research service provides a complete analysis of the diagnostic imaging market in India. It quantifies market size, provides insight into the burdens of diseases in India, and examines market dynamics from 2011 to 2018. It provides an in-depth analysis of the competitive environment by highlighting the markets competitive structure and the la...

This research study provides an analysis of the in vitro diagnostics (IVD) market in India. It quantifies market size, provides insight into the burden of diseases in India, and examines market dynamics from 2007 to 2017. It provides an in-depth analysis of the competitive environment by highlighting the competitive structure, diagnostic service la...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

30 Apr 2020  |  Asia Pacific  |  Market Outlook

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

Infographics

×

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...

14 Feb 2020  |  Asia Pacific  |  Market Research

Select Diagnostic Imaging Equipment Market Landscape in Malaysia, Forecast to 2023

New Budget Allocations, Expansions in Private Sector, and Time to Market on Next-generation Imaging Equipment Opens Up Robust Market Opportunities

Infographics

×

This study presents an analysis of the Malaysian diagnostic imaging equipment market. It provides an in-depth analysis of the current trends, market size, and revenue forecast, and market penetration, market attractiveness, in digital radiography, ultrasound, computed tomography, magnetic resonance imaging, interventional X-ray, and fluoroscopy. M...